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CORRESPONDENCE
The Author Response
EML4-ALK Fusion Gene in Korean Non-Small Cell Lung Cancer
Jae Yong Park
Department of Biochemistry and Cell Biology, and Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea
I would like to thank the interest and comments on our paper 
entitled “EML4-ALK fusion gene in Korean non-small cell lung 
cancer” (1). In this study, we examined EML4-ALK fusion vari-
ants in Korean non-small cell lung cancers (NSCLCs) via reverse-
transcriptase-polymerase chain reaction (RT-PCR) using prim-
ers designed to detect EML4-ALK fusion variants (variants 1, 2, 
3a, 3b, 4, 5a, 5b, 6, and 7) that have been previously identified  
(2, 3). Our study demonstrated the spectrum and frequency of 
EML4-ALK fusion variants in Korean NSCLCs, which were dif-
ferent from those in other ethnic populations.
  I agree with the comment that the RT-PCR technology for iden-
tification of ALK fusion variants has several limitations. As point-
ed out in this comment, there are multiple EML4-ALK fusion 
variants and non-EML4 fusion partners, such as KIF5B, and 
KLC1 (2-5); therefore, any PCR-based strategy must incorpo-
rate validated primer pairs for all known ALK fusions. Another 
limitation is that given that most specimens from lung cancer 
patients are stored as formalin-fixed paraffin embedded tissue, 
the RNA may have been substantially degraded relative to non-
fixed, fresh-frozen tissue. In addition, it has been reported that 
PCR-based detection of EML4-ALK can yield positive results in 
the absence of detectable ALK-rearrangement in both tumor 
and non-tumor tissues, suggesting a propensity for false posi-
tive results (6). The aim of our study was to examine the profile 
of known EML4-ALK fusion variants in Korean NSCLCs and was 
not to detect the presence of ALK fusion to other gene partners. 
The limitations of the RT-PCR analysis, such as the necessity of 
available high-quality RNA and the propensity of false positive 
results, were briefly discussed in the paper. I agree with the sug-
gestion that long-distance-PCR or long distance inverse-PCR 
could be used to identify all EML4-ALK fusion variants as well 
as other ALK rearrangements having known or even unknown 
fusion partner genes (7, 8). 
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